No Data
No Data
Timber Pharmaceuticals Announces Bankruptcy and Investment Risks
Timber Pharmaceuticals Files for Chapter 11 Bankruptcy
Timber Pharmaceuticals Announces Official Name Change
LEO Pharma Finalizes Acquisition of Key Assets From Timber Pharmaceuticals
Strategic acquisition to expand pipeline, accelerate growth, and meet unmet needs in medical dermatology. LEO Pharma today announced that it has finalized the acquisition of the strategic asset TMB-001 as well as
Global Lamellar Icthyosis Pipeline Research Report 2023 Featuring Timber Pharmaceuticals, Krystal Biotech, and Janssen
Timber Pharmaceuticals Suspended From Trading on NYSE American
No Data